摘要
健康权是我国宪法规定的基本权利,保障药品可及是落实这一权利的必然选择。"抗癌药代购第一人"陆勇案件折射出我国消费者权利与药品专利权人权利的利益平衡问题。基于我国医疗科学技术、经济发展水平限制,中国亟待在WTO框架下,借鉴相关国家经验,制定完善我国专利药品的消费者权益保护制度,加快药品消费者保护立法的国际化和统一化。
Health right is the basic right in our constitution. Ensuring drugs available is crucial and a necessary choice to the implementation of this right. The case of Luyong is a reflection of the benefit balance problem between the rights of consumers and patentees in China. Based on the limited medical science and technology as well as the economic development in China,it is very urgent to be perfect in the field of drug patents for consumer right protections,which can be inspired by the experience of relative nations under the framework of WTO.
作者
周易茗
ZHOU Yi-ming(Party School of the Hunan Provincial Committee of C.P.C,Changsha,Hunan 410000)
出处
《怀化学院学报》
2019年第3期73-79,共7页
Journal of Huaihua University
基金
国家社科基金项目"药品消费者保护中的国际私法问题研究"(14BFX033)